Average Co-Inventor Count = 4.13
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Burroughs Wellcome Co. (13 from 521 patents)
2. Glaxo Wellcome Inc. (4 from 281 patents)
3. Triangle Pharmaceuticals, Inc. (4 from 6 patents)
4. Smithkline Beecham Corporation (2 from 2,198 patents)
5. Gilead Sciences, Inc. (1 from 920 patents)
6. Glaxosmithkline LLC (1 from 356 patents)
25 patents:
1. 7572800 - Combination therapy to treat hepatitis B virus
2. 6544961 - Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatments of HIV
3. 6528515 - Combination therapy to treat hepatitis B virus
4. 6486136 - Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV
5. 6417191 - Synergistic combinations of zidovudine, 1592U89 and 3TC
6. 6410546 - Use of MKC-442 in combination with other antiviral agents
7. 6188988 - Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
8. 6081786 - Systems, methods and computer program products for guiding the selection
9. 5885957 - Treatment of HTLV-I infections
10. 5877163 - Treatment of human viral infections
11. 5683990 - Treatment of human viral infections
12. 5643891 - Treatment of viral infections
13. 5145840 - Treatment of idiopathic thrombocytopaenic purpura
14. 5093114 - Treatment of human viral infections
15. 5086044 - Treatment of human viral infections